Screening and management of potentially treatable genetic metabolic disorders

Name: Screening and management of potentially treatable genetic metabolic disorders
Brand: Springer Nature
SKU: 9780852007846
Availability: InStock

Best Price (Coupon Required):
Buy Screening and management of potentially treatable genetic metabolic disorders for $153.00 at @ Link.springer.com when you apply the 10% OFF coupon at checkout.
Click “Get Coupon & Buy” to copy the code and unlock the deal.

Set a price drop alert to never miss an offer.

1 Offer Price Range: $169.99 - $169.99

BEST PRICE

Single Product Purchase

$153.00

@ Link.springer.com with extra coupon

Price Comparison

Seller	Contact Seller	List Price	On Sale	Shipping	Best Promo	Final Price	Volume Discount	Financing	Availability	Seller's Page
BEST PRICE 1 Product Purchase @ Link.springer.com		$169.99	$169.99		10% OFF This deals requires coupon	$153.00		See Site	In stock	Visit Store

Product Details

Brand

Springer Nature

Manufacturer

N/A

Part Number

GTIN

9780852007846

Condition

New

Product Description

1 The success of early diagnosis and therefore of treatment of phe nylketonuria, inevitably suggests the possibility of early screening and treatment of other genetic metabolic abnormalities. This volume contains a summary of papers delivered at a Workshop on "Recent Advances in Screening and Management of Potentially Trea table Genetic Metabolic Disorders" held under the auspices of the Com mission of the European Communi ties, in London, U. K., on the 17th and 18th March 1983 to consider such possibilities. The Workshop was not aimed at those disorders for which the prin ciples of treatment and management have been soundly established, or for which screening procedures are in general use. The papers therefore do not form a comprehensive account of metabolic disorders. The topics for discussion were selected mainly to highlight recent discoveries which might be exploited by concerted approaches between different cen tres, especially when the immediate benefits were restricted to only a few centres. Recent reports suggest that about 2% of infants with persistent hyperphenylaninaemia do not respond to treatment by phenylalanine - low diets, and develop severe brain damage. Infants with such "Malignant Hyperphenylalaninaemia" due to one of several genetic causes of tetrahy drobiopterin deficiency should be rapidly identi fied since there is evidence that appropriate treatment will prevent brain damage. The Workshop considered how appropriate screening could be made generally available.

Available Colors

N/A

Available Sizes

N/A